Eton Pharmaceuticals
ETON
Eton Pharmaceuticals (ETON) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $0.43
- EPS estimate
- $0.15
- EPS surprise
- +191.72%
- Revenue surprise
- +38.67%
- Revenue
- $37.6M
- Revenue estimate
- $27.1M
- Reported
- Aug 13, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | $0.15 | $0.43 | +191.72% | $37.6M | SEC |
| Q1 2026 | May 14, 2026 | $0.11 | $0.14 | +23.57% | $24.3M | SEC |
| Q4 2025 | Mar 19, 2026 | $0.13 | $0.17 | +27.53% | $21.3M | SEC |
| Q3 2025 | Nov 6, 2025 | $0.09 | $0.04 | −55.56% | $22.5M | SEC |
| Q2 2025 | Aug 7, 2025 | −$0.04 | −$0.10 | −172.48% | $18.9M | SEC |
| Q1 2025 | May 13, 2025 | $0.05 | −$0.06 | −212.57% | $17.3M | SEC |
| Q4 2024 | Mar 18, 2025 | −$0.00 | −$0.02 | −506.06% | $11.6M | SEC |
| Q3 2024 | Nov 12, 2024 | −$0.01 | $0.02 | +300.00% | $10.3M | SEC |
| Q2 2024 | Aug 8, 2024 | −$0.07 | −$0.12 | −71.43% | $9.1M | SEC |
| Q1 2024 | May 9, 2024 | −$0.07 | −$0.03 | +57.14% | $8.0M | SEC |
| Q4 2023 | Mar 14, 2024 | −$0.04 | −$0.09 | −125.00% | $7.3M | SEC |
| Q3 2023 | Nov 9, 2023 | −$0.10 | −$0.02 | +80.00% | $7.0M | SEC |
| Q2 2023 | Aug 10, 2023 | −$0.09 | $0.18 | +300.00% | $12.0M | SEC |
| Q1 2023 | May 11, 2023 | −$0.14 | −$0.10 | +28.57% | $5.3M | SEC |
| Q4 2022 | Mar 16, 2023 | $0.01 | $0.04 | +300.00% | $8.5M | SEC |
| Q3 2022 | Nov 10, 2022 | −$0.15 | −$0.12 | +20.00% | $3.2M | — |
| Q2 2022 | Aug 11, 2022 | $0.03 | −$0.06 | −300.00% | $7.4M | — |
| Q1 2022 | May 12, 2022 | −$0.08 | −$0.21 | −162.50% | $2.2M | — |
| Q4 2021 | Mar 16, 2022 | $0.05 | $0.04 | −20.00% | $6.1M | — |
| Q3 2021 | Nov 15, 2021 | −$0.14 | −$0.24 | −77.78% | $775,000.00 | — |
Quarterly revenue
Frequently asked questions
When did Eton Pharmaceuticals (ETON) last report earnings?
Eton Pharmaceuticals last reported on Aug 13, 2026, covering fiscal Q2 2026.
Did ETON beat earnings estimates?
Yes. Eton Pharmaceuticals reported EPS of $0.43 for Q2 2026 against a $0.15 estimate — a 191.72% beat.
How much revenue did ETON report last quarter?
Eton Pharmaceuticals reported $37.6M in revenue for Q2 2026, against a consensus estimate of $27.1M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.